These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 23681608)

  • 1. Moving from basic toward systems pharmacodynamic models.
    Jusko WJ
    J Pharm Sci; 2013 Sep; 102(9):2930-40. PubMed ID: 23681608
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transitioning from Basic toward Systems Pharmacodynamic Models: Lessons from Corticosteroids.
    Ayyar VS; Jusko WJ
    Pharmacol Rev; 2020 Apr; 72(2):414-438. PubMed ID: 32123034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Basic concepts of pharmacokinetic/pharmacodynamic (PK/PD) modelling.
    Meibohm B; Derendorf H
    Int J Clin Pharmacol Ther; 1997 Oct; 35(10):401-13. PubMed ID: 9352388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Application of pharmacometrics and quantitative systems pharmacology to cancer therapy: The example of luminal a breast cancer.
    Fleisher B; Brown AN; Ait-Oudhia S
    Pharmacol Res; 2017 Oct; 124():20-33. PubMed ID: 28735000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systems pharmacology and enhanced pharmacodynamic models for understanding antibody-based drug action and toxicity.
    Ait-Oudhia S; Ovacik MA; Mager DE
    MAbs; 2017 Jan; 9(1):15-28. PubMed ID: 27661132
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modeling of pharmacokinetic/pharmacodynamic (PK/PD) relationships: concepts and perspectives.
    Derendorf H; Meibohm B
    Pharm Res; 1999 Feb; 16(2):176-85. PubMed ID: 10100300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of Physiologically Based Pharmacokinetics, Population Pharmacokinetics and Pharmacokinetics/Pharmacodynamics in the Development of Antibody-Drug Conjugates.
    Li C; Chen SC; Chen Y; Girish S; Kaagedal M; Lu D; Lu T; Samineni D; Jin JY
    J Clin Pharmacol; 2020 Oct; 60 Suppl 1(Suppl 1):S105-S119. PubMed ID: 33205423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incorporating receptor theory in mechanism-based pharmacokinetic-pharmacodynamic (PK-PD) modeling.
    Ploeger BA; van der Graaf PH; Danhof M
    Drug Metab Pharmacokinet; 2009; 24(1):3-15. PubMed ID: 19252332
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Automated analysis of routinely generated preclinical pharmacokinetic and pharmacodynamic data.
    Lindhardt E; Gennemark P
    J Bioinform Comput Biol; 2014 Jun; 12(3):1450010. PubMed ID: 24969748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sobol Sensitivity Analysis: A Tool to Guide the Development and Evaluation of Systems Pharmacology Models.
    Zhang XY; Trame MN; Lesko LJ; Schmidt S
    CPT Pharmacometrics Syst Pharmacol; 2015 Feb; 4(2):69-79. PubMed ID: 27548289
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Scaling pharmacodynamics from in vitro and preclinical animal studies to humans.
    Mager DE; Woo S; Jusko WJ
    Drug Metab Pharmacokinet; 2009; 24(1):16-24. PubMed ID: 19252333
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative structure-pharmacokinetic/pharmacodynamic relationships.
    Mager DE
    Adv Drug Deliv Rev; 2006 Nov; 58(12-13):1326-56. PubMed ID: 17092600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetic-pharmacodynamic modelling: history and perspectives.
    Csajka C; Verotta D
    J Pharmacokinet Pharmacodyn; 2006 Jun; 33(3):227-79. PubMed ID: 16404503
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristics of indirect pharmacodynamic models and applications to clinical drug responses.
    Sharma A; Jusko WJ
    Br J Clin Pharmacol; 1998 Mar; 45(3):229-39. PubMed ID: 9517366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetic-pharmacodynamic modeling: why?
    Pérez-Urizar J; Granados-Soto V; Flores-Murrieta FJ; Castañeda-Hernández G
    Arch Med Res; 2000; 31(6):539-45. PubMed ID: 11257318
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative pharmacology or pharmacokinetic pharmacodynamic integration should be a vital component in integrative pharmacology.
    Gabrielsson J; Green AR
    J Pharmacol Exp Ther; 2009 Dec; 331(3):767-74. PubMed ID: 19779129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetic-pharmacodynamic models that incorporate drug-target binding kinetics.
    Daryaee F; Tonge PJ
    Curr Opin Chem Biol; 2019 Jun; 50():120-127. PubMed ID: 31030171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetic-pharmacodynamic model for educational simulations.
    van Meurs WL; Nikkelen E; Good ML
    IEEE Trans Biomed Eng; 1998 May; 45(5):582-90. PubMed ID: 9581056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The integration of pharmacokinetics and pharmacodynamics: understanding dose-response.
    Abdel-Rahman SM; Kauffman RE
    Annu Rev Pharmacol Toxicol; 2004; 44():111-36. PubMed ID: 14744241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetic/pharmacodynamic modeling in drug research and development.
    Derendorf H; Lesko LJ; Chaikin P; Colburn WA; Lee P; Miller R; Powell R; Rhodes G; Stanski D; Venitz J
    J Clin Pharmacol; 2000 Dec; 40(12 Pt 2):1399-418. PubMed ID: 11185661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.